Persons of younger ages have also been found to present with severe form of the disease along with complication such as obesity, higher degrees of insulin resistance and rapidly increasing blood glucose [44] which may explain the high use of insulin in this group compared to sulphonylurea medications [45]. This evidence concerns the gene INS and obesity disorder.